379 related articles for article (PubMed ID: 17764789)
1. Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans.
Etchart N; Hennino A; Friede M; Dahel K; Dupouy M; Goujon-Henry C; Nicolas JF; Kaiserlian D
Vaccine; 2007 Sep; 25(39-40):6891-9. PubMed ID: 17764789
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241
[TBL] [Abstract][Full Text] [Related]
3. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M
Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858
[No Abstract] [Full Text] [Related]
4. Measles vaccination of macaques by dry powder inhalation.
de Swart RL; LiCalsi C; Quirk AV; van Amerongen G; Nodelman V; Alcock R; Yüksel S; Ward GH; Hardy JG; Vos H; Witham CL; Grainger CI; Kuiken T; Greenspan BJ; Gard TG; Osterhaus AD
Vaccine; 2007 Jan; 25(7):1183-90. PubMed ID: 17084489
[TBL] [Abstract][Full Text] [Related]
5. Aerosol measles vaccination in macaques: preclinical studies of immune responses and safety.
de Swart RL; Kuiken T; Fernandez-de Castro J; Papania MJ; Bennett JV; Valdespino JL; Minor P; Witham CL; Yüksel S; Vos H; van Amerongen G; Osterhaus AD
Vaccine; 2006 Sep; 24(40-41):6424-36. PubMed ID: 16934375
[TBL] [Abstract][Full Text] [Related]
6. Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic.
Guerbois M; Moris A; Combredet C; Najburg V; Ruffié C; Février M; Cayet N; Brandler S; Schwartz O; Tangy F
Virology; 2009 May; 388(1):191-203. PubMed ID: 19345390
[TBL] [Abstract][Full Text] [Related]
7. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
[TBL] [Abstract][Full Text] [Related]
8. Measles IgA in the nasal washings of adult volunteers and children immunized intranasally with measles vaccine L-16.
Liashenko VA; Krasnova VP; Youminova NV
Hum Antibodies; 1999; 9(3):143-8. PubMed ID: 10690626
[TBL] [Abstract][Full Text] [Related]
9. Measles vaccination: new strategies and formulations.
de Vries RD; Stittelaar KJ; Osterhaus AD; de Swart RL
Expert Rev Vaccines; 2008 Oct; 7(8):1215-23. PubMed ID: 18844595
[TBL] [Abstract][Full Text] [Related]
10. Influence of the specific T cell response on seroconversion after measles vaccination in autologous bone marrow transplant patients.
Pauksen K; Linde A; Lönnerholm G; Ljungman P; Sjölin J
Bone Marrow Transplant; 1996 Nov; 18(5):969-73. PubMed ID: 8932853
[TBL] [Abstract][Full Text] [Related]
11. Development of a dendritic cell vaccine against measles for patients following hematopoietic cell transplantation.
Nashida Y; Kumamoto T; Azuma E; Hirayama M; Araki M; Yamada H; Dida F; Iwamoto S; Tamaki S; Ido M; Ihara T; Komada Y
Transplantation; 2006 Oct; 82(8):1104-7. PubMed ID: 17060861
[TBL] [Abstract][Full Text] [Related]
12. Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines.
Brandler S; Tangy F
Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):271-91. PubMed ID: 17869338
[TBL] [Abstract][Full Text] [Related]
13. Will the current measles vaccines ever eradicate measles?
Stephenson J
Expert Rev Vaccines; 2002 Oct; 1(3):355-62. PubMed ID: 12901574
[TBL] [Abstract][Full Text] [Related]
14. Detection of measles virus-specific interferon-gamma-secreting T-cells by ELISPOT.
Ryan JE; Ovsyannikova IG; Poland GA
Methods Mol Biol; 2005; 302():207-18. PubMed ID: 15937354
[TBL] [Abstract][Full Text] [Related]
15. Studies on measles in Thailand. VI. A clinical trial of "CAM 70" measles virus vaccine in home-dwelling children.
Sangkawibha N; Ueda S; Tuchinda P; Sakuntanaga P; Sunthonsaratul A
Biken J; 1973 Dec; 16(4):167-71. PubMed ID: 4799209
[No Abstract] [Full Text] [Related]
16. Measles vaccine in the People's Republic of China.
Xiang JZ; Chen ZH
Rev Infect Dis; 1983; 5(3):506-10. PubMed ID: 6879006
[TBL] [Abstract][Full Text] [Related]
17. Measles susceptibility in two Pacific atoll populations. Epidemiological factors and response to live attenuated measles virus.
Willis MF; Warburton MF
Med J Aust; 1974 May; 1(20):789-93. PubMed ID: 4853112
[No Abstract] [Full Text] [Related]
18. Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants.
Gatchalian S; Yao Y; Zhou B; Zhang L; Yoksan S; Kelly K; Neuzil KM; Yaïch M; Jacobson J
Vaccine; 2008 Apr; 26(18):2234-41. PubMed ID: 18394765
[TBL] [Abstract][Full Text] [Related]
19. [Specific prevention of measles in Rumania. V. Studies on an attenuated live measles virus vaccine prepared at the Stefan S. Nicolau Institute of Virology and administered in various ways].
Cajal N; Cepleanu M; Cernesc C; Sorodoc Y; Tigăeru N; Biberi-Moroianu S; Cuciu D; Brebenel G; Vucu E; Petrescu A
Stud Cercet Virusol; 1973; 24(5):349-56. PubMed ID: 4747453
[No Abstract] [Full Text] [Related]
20. [Clinical and serological studies with a live further attenuated measles vaccine (Moraten) in Chile].
Ristori C; Boccardo H; Borgoño JM; Greiber R; Heras E; Carrillo B; Solari G; Concha F
Rev Med Chil; 1970 Jan; 98(1):42-5. PubMed ID: 4157374
[No Abstract] [Full Text] [Related]
[Next] [New Search]
